<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK537476" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK537476/" /><meta name="ncbi_pagename" content="SLC12A5-Related Epilepsy of Infancy with Migrating Focal Seizures - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>SLC12A5-Related Epilepsy of Infancy with Migrating Focal Seizures - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="SLC12A5-Related Epilepsy of Infancy with Migrating Focal Seizures" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/02/14" /><meta name="citation_author" content="Amy McTague" /><meta name="citation_author" content="Manju A Kurian" /><meta name="citation_pmid" content="30763027" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK537476/" /><meta name="citation_keywords" content="Early-Infantile Epileptic Encephalopathy 34 (EIEE34)" /><meta name="citation_keywords" content="SLC12A5-EIMFS" /><meta name="citation_keywords" content="Early-Infantile Epileptic Encephalopathy 34 (EIEE34)" /><meta name="citation_keywords" content="SLC12A5-EIMFS" /><meta name="citation_keywords" content="Solute carrier family 12 member 5" /><meta name="citation_keywords" content="SLC12A5" /><meta name="citation_keywords" content="SLC12A5-Related Epilepsy of Infancy with Migrating Focal Seizures" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="SLC12A5-Related Epilepsy of Infancy with Migrating Focal Seizures" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Amy McTague" /><meta name="DC.Contributor" content="Manju A Kurian" /><meta name="DC.Date" content="2019/02/14" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK537476/" /><meta name="description" content="SLC12A5-related epilepsy of infancy with migrating focal seizures (SLC12A5-EIMFS), reported to date in nine children, is characterized by onset of seizures before age six months and either developmental delay or developmental regression with seizure onset. Of these nine children, six had severe developmental delay with no progress of abilities and three made notable neurodevelopmental progress. Eight had postnatal microcephaly and hypotonia. In most children epilepsy begins as focal motor seizures (typically involving head and eye deviation) that become multifocal and intractable to conventional antiepileptic drugs (AEDs)." /><meta name="og:title" content="SLC12A5-Related Epilepsy of Infancy with Migrating Focal Seizures" /><meta name="og:type" content="book" /><meta name="og:description" content="SLC12A5-related epilepsy of infancy with migrating focal seizures (SLC12A5-EIMFS), reported to date in nine children, is characterized by onset of seizures before age six months and either developmental delay or developmental regression with seizure onset. Of these nine children, six had severe developmental delay with no progress of abilities and three made notable neurodevelopmental progress. Eight had postnatal microcephaly and hypotonia. In most children epilepsy begins as focal motor seizures (typically involving head and eye deviation) that become multifocal and intractable to conventional antiepileptic drugs (AEDs)." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK537476/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/slc12a5-e/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK537476/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A1EC4DFC8E3610000000002E30173.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK537476_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK537476_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/lwd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/slc39a14-def/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK537476_"><span class="title" itemprop="name"><i>SLC12A5</i>-Related Epilepsy of Infancy with Migrating Focal Seizures</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Early-Infantile Epileptic Encephalopathy 34 (EIEE34), <i>SLC12A5</i>-EIMFS</div><p class="contrib-group"><span itemprop="author">Amy McTague</span>, MBChB and <span itemprop="author">Manju A Kurian</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK537476_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK537476_ai__"><div class="contrib half_rhythm"><span itemprop="author">Amy McTague</span>, MBChB<div class="affiliation small">UCL Great Ormond Street Institute of Child Health<br />University College London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcu@eugatcm.a" class="oemail">ku.ca.lcu@eugatcm.a</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Manju A Kurian</span>, PhD<div class="affiliation small">UCL Great Ormond Street Institute of Child Health<br />University College London<br />London, United Kingdom<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ku.ca.lcu@nairuk.ujnam" class="oemail">ku.ca.lcu@nairuk.ujnam</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 14, 2019</span>.</p><p><em>Estimated reading time: 19 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="slc12a5-e.Summary" itemprop="description"><h2 id="_slc12a5-e_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>SLC12A5</i>-related epilepsy of infancy with migrating focal seizures (<i>SLC12A5</i>-EIMFS), reported to date in nine children, is characterized by onset of seizures before age six months and either developmental delay or developmental regression with seizure onset. Of these nine children, six had severe developmental delay with no progress of abilities and three made notable neurodevelopmental progress. Eight had postnatal microcephaly and hypotonia. In most children epilepsy begins as focal motor seizures (typically involving head and eye deviation) that become multifocal and intractable to conventional antiepileptic drugs (AEDs).</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>SLC12A5</i>-EIMFS is established by identification of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SLC12A5</i> pathogenic variants on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> There are no specific treatments for seizures in <i>SLC12A5</i>-EIMFS. In general, seizures in EIMFS are resistant to most AEDs. A ketogenic diet and potassium bromide showed attenuation of seizures in three patients each. A multidisciplinary approach to management of hypotonia, feeding difficulties, respiratory problems, and developmental delay is recommended.</p><p><i>Surveillance:</i> Routine monitoring of: feeding, nutritional status, swallowing, gastroesophageal reflux, aspiration, and respiratory problems; back for scoliosis and hips for dislocation with spine and hip x-rays; effectiveness of seizure control; development including motor skills, speech/language, and general cognitive and vocational skills.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>SLC12A5</i>-EIMFS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. The parents of a child with <i>SLC12A5</i>-EIMFS are typically heterozygotes (i.e., carriers of one <i>SLC12A5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>). Heterozygous parents of a child with <i>SLC12A5</i>-EIMFS are not at risk of developing EIMFS. When both parents are heterozygotes (carriers) each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Once the <i>SLC12A5</i> pathogenic variants have been identified in an affected family member, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk relatives, prenatal testing for a pregnancy at increased risk, and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p></div></div><div id="slc12a5-e.Diagnosis"><h2 id="_slc12a5-e_Diagnosis_">Diagnosis</h2><p>Since 2010 a description of the characteristic symptoms and findings of epilepsy of infancy with migrating focal seizures (EIMFS) has been included in the classification of epilepsy syndromes by the International League Against Epilepsy. The diagnosis of <i>SLC12A5</i>-EIMFS is established by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><div id="slc12a5-e.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>SLC12A5</i>-related epilepsy of infancy with migrating focal seizures (<i>SLC12A5</i>-EIMFS) <b>should be considered</b> in children with the following epilepsy and electroencephalogram (EEG) findings and family history.</p><p><b>Epilepsy features</b></p><ul><li class="half_rhythm"><div>Seizure onset before age six months</div></li><li class="half_rhythm"><div>Developmental delay or developmental regression with seizure onset</div></li></ul><p><b>Seizure type</b></p><ul><li class="half_rhythm"><div>At onset in most children: focal motor seizures that also frequently involve head and eye deviation</div></li><li class="half_rhythm"><div>Multifocal seizures proving intractable to conventional antiepileptic drugs</div></li></ul><p><b>Epilepsy syndromes.</b> Epilepsy of infancy with migrating focal seizures</p><p><b>EEG findings</b></p><ul><li class="half_rhythm"><div>Interictal multifocal spikes</div></li><li class="half_rhythm"><div>In a single seizure, ictal-independent, unilateral, and migrating involvement of varying cortical areas with clinical-EEG correlation</div></li><li class="half_rhythm"><div>Initial EEG may be normal shortly after seizure onset, but epileptiform abnormalities are usually present within one month after first presentation.</div></li><li class="half_rhythm"><div>Migrating ictal foci may not be seen for several months after presentation.</div></li></ul><p><b>Family history.</b> Consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance, including parental <a class="def" href="/books/n/gene/glossary/def-item/consanguinity/">consanguinity</a> or more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child</p></div><div id="slc12a5-e.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of <i>SLC12A5</i>-EIMFS <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SLC12A5</i> pathogenic variants identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK537476/table/slc12a5-e.T.molecular_genetic_testing_us/?report=objectonly" target="object" rid-figpopup="figslc12a5eTmoleculargenetictestingus" rid-ob="figobslc12a5eTmoleculargenetictestingus">Table 1</a>).</p><p>Due to the genetic heterogeneity of early-onset epilepsy, use of either a multigene epilepsy panel or comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> or <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) is the preferred initial approach [<a class="bk_pop" href="#slc12a5-e.REF.mctague.2016.304">McTague et al 2016</a>]. Note: Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (<a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>SLC12A5</i>, followed by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>) is rarely useful and typically NOT recommended.</p><div id="slc12a5-e.Testing_Options_to_Consider"><h4>Testing Options to Consider</h4><p><b>An epilepsy <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>SLC12A5</i> and other genes of interest (see <a href="#slc12a5-e.Differential_Diagnosis">Differential Diagnosis</a>) typically provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting identification of pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. Of note, given the rarity of <i>SLC12A5</i>-related epilepsy, some epilepsy panels may not include this gene. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><p><b>Comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is another good option. <b>Exome sequencing</b> is most commonly used; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>If <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> is not diagnostic, <b><a class="def" href="/books/n/gene/glossary/def-item/exome-array/">exome array</a></b> (when clinically available) may be considered to detect (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications that cannot be detected by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="slc12a5-e.T.molecular_genetic_testing_us" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>SLC12A5</i>-EIMFS</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK537476/table/slc12a5-e.T.molecular_genetic_testing_us/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__slc12a5-e.T.molecular_genetic_testing_us_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_slc12a5-e.T.molecular_genetic_testing_us_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_slc12a5-e.T.molecular_genetic_testing_us_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_slc12a5-e.T.molecular_genetic_testing_us_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_slc12a5-e.T.molecular_genetic_testing_us_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC12A5</i></td><td headers="hd_h_slc12a5-e.T.molecular_genetic_testing_us_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_slc12a5-e.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">9/9 (100%)&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_slc12a5-e.T.molecular_genetic_testing_us_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_slc12a5-e.T.molecular_genetic_testing_us_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown (no data available)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="slc12a5-e.TF.1.1"><p class="no_margin">See <a href="/books/n/gene/slc12a5/#slc12a5.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="slc12a5-e.TF.1.2"><p class="no_margin">See <a href="#slc12a5-e.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="slc12a5-e.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="slc12a5-e.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.st_dberg.2015.8038">St&#x000f6;dberg et al [2015]</a>, <a class="bk_pop" href="#slc12a5-e.REF.saitsu.2016.30072">Saitsu et al [2016]</a>, <a class="bk_pop" href="#slc12a5-e.REF.saito.2017.654">Saito et al [2017]</a></p></div></dd><dt>5. </dt><dd><div id="slc12a5-e.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd></dl></div></div></div></div></div></div><div id="slc12a5-e.Clinical_Characteristics"><h2 id="_slc12a5-e_Clinical_Characteristics_">Clinical Characteristics</h2><div id="slc12a5-e.Clinical_Description"><h3>Clinical Description</h3><p><i>SLC12A5</i>-related epilepsy of infancy with migrating focal seizures (<i>SLC12A5</i>-EIMFS) is characterized by severe early-onset epileptic encephalopathy, with a distinct electroclinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> that is common to all EIMFS regardless of cause. To date nine children have been reported with <i>SLC12A5</i>-EIMFS [<a class="bk_pop" href="#slc12a5-e.REF.st_dberg.2015.8038">St&#x000f6;dberg et al 2015</a>, <a class="bk_pop" href="#slc12a5-e.REF.saitsu.2016.30072">Saitsu et al 2016</a>, <a class="bk_pop" href="#slc12a5-e.REF.saito.2017.654">Saito et al 2017</a>].</p><p><b>Seizures.</b> In the nine children reported, three clinical stages were evident:</p><ul><li class="half_rhythm"><div>An <b>early stage</b> with emerging focal seizures. Median age of seizure onset was 1.5 months; mean age 1.8 months (range: 1 day - 4 months).</div><ul><li class="half_rhythm"><div>Seizures are characterized by apnea and focal clonic and tonic seizures with prominent head and eye deviation.</div></li><li class="half_rhythm"><div>Subtle seizures with behavioral arrest, apnea, and cyanosis or generalized tonic or tonic-clonic seizures are also seen at onset. All children eventually develop focal motor seizures.</div></li><li class="half_rhythm"><div>Clinically migrating seizures (which affect differing or alternating body parts) are seen in approximately 50% of children.</div></li><li class="half_rhythm"><div>Autonomic features such as facial flushing, salivation, apnea, and cyanosis are common.</div></li></ul></li><li class="half_rhythm"><div>A <b>second stage</b> with up to 200 seizures per day at the peak of the seizures, usually at a median age of 16 weeks (range: 1-40 weeks). Either focal status epilepticus or frequent clusters of focal seizures are seen.</div></li><li class="half_rhythm"><div>A <b>late stage</b> (age &#x0003e;1-2 years) with a reduction of seizure frequency. Of the four children who had seizure-free periods, two relapsed to frequent recurrent seizures.</div></li></ul><p><b>Developmental delay</b> was seen in all nine children. Five children experienced developmental regression (i.e., loss of previously acquired skills) at seizure onset.</p><p>Severe developmental delay with no progression of skills was seen in six of the nine. In contrast, three of the nine had notable neurodevelopmental progress, either regaining lost skills or acquiring new skills during periods of good seizure control. Two achieved independent ambulation (at ages 2.9 and 4 years) and one spoke single words at age six years.</p><p><b>Other</b></p><ul><li class="half_rhythm"><div>Postnatal (i.e., acquired) microcephaly and hypotonia was noted in eight of the nine children.</div></li><li class="half_rhythm"><div>Of the four for whom feeding information was available, two had feeding difficulties; none had growth failure.</div></li><li class="half_rhythm"><div>One had unilateral pyramidal signs.</div></li><li class="half_rhythm"><div>Hyperkinetic movement disorders, seen in other causes of EIMFS including <i>KCNT1</i> and <i>SCN2A</i>, have not been reported in <i>SLC12A5</i>-EIMFS [<a class="bk_pop" href="#slc12a5-e.REF.howell.2015.958">Howell et al 2015</a>, <a class="bk_pop" href="#slc12a5-e.REF.mctague.2018.e55">McTague et al 2018</a>].</div></li></ul><p><b>Outcome.</b> One child with frequent seizures died at age 2.5 years from respiratory infection and cardiac arrest [<a class="bk_pop" href="#slc12a5-e.REF.st_dberg.2015.8038">St&#x000f6;dberg et al 2015</a>]; the others with <i>SLC12A5</i>-EIMFS (ages 3-22 years) are living as of this writing.</p><p><b>Electroencephalogram (EEG).</b> Eight children had ictal EEGs consistent with a diagnosis of EIMFS. Early EEGs were not available for one child; thus, a formal diagnosis could not be made despite a clinical history consistent with EIMFS.</p><p>Interictal EEG features included background slowing and multifocal abnormalities.</p><p><b>MRI findings.</b> The following nonspecific MRI features of EIMFS have been observed in <i>SLC12A5</i>-EIMFS:</p><ul><li class="half_rhythm"><div>Delayed myelination</div></li><li class="half_rhythm"><div>Thin corpus callosum</div></li><li class="half_rhythm"><div>Cerebral atrophy, either predominantly frontal or global</div></li><li class="half_rhythm"><div>Increased signal in white matter on diffusion-weighted imaging</div></li></ul><p>The following focal abnormalities have been reported in <i>SLC12A5</i>-EIMFS:</p><ul><li class="half_rhythm"><div>Unilateral hippocampal sclerosis noted at age four years (n=1) [<a class="bk_pop" href="#slc12a5-e.REF.saito.2017.654">Saito et al 2017</a>]</div></li><li class="half_rhythm"><div>Cerebellar atrophy and bilateral hippocampal atrophy with increased signal on FLAIR imaging at ages ten and 20 years in the oldest individual imaged to date [<a class="bk_pop" href="#slc12a5-e.REF.saitsu.2016.30072">Saitsu et al 2016</a>]. It is unclear if these findings represent the typical progression of imaging findings in <i>SLC12A5</i>-EIMFS as all other individuals imaged were age four years or younger.</div></li></ul><p>Magnetic resonance spectroscopy (MRS) in a child age eight months demonstrated reduction in the relative N-acetyl aspartate peak, consistent with delayed maturation of myelin [<a class="bk_pop" href="#slc12a5-e.REF.st_dberg.2015.8038">St&#x000f6;dberg et al 2015</a>].</p></div><div id="slc12a5-e.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>No clear correlation exists between <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SLC12A5</i> variants and <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, which may reflect the limited number of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reported to date.</p></div><div id="slc12a5-e.Nomenclature"><h3>Nomenclature</h3><p>EIMFS is a type of early-infantile epileptic encephalopathy (EIEE); OMIM classifies <i>SLC12A5</i>-related epilepsy as EIEE34.</p><p>Terms previously used for EIMFS include the following:</p><ul><li class="half_rhythm"><div>Migrating partial seizures of infancy (MPSI)</div></li><li class="half_rhythm"><div>Malignant migrating partial seizures of infancy (MMPSI)</div></li><li class="half_rhythm"><div>Migrating focal seizures of infancy (MFSI)</div></li></ul><p><i>SLC12A5</i>-related epilepsy includes EIMFS and EIMFS-like severe early-onset epileptic encephalopathy (EIEE with some features of EIMFS but not fulfilling all criteria; e.g., when EEG is not available).</p></div><div id="slc12a5-e.Prevalence"><h3>Prevalence</h3><p>To date, nine probands with <i>SLC12A5-</i>related epilepsy have been reported.</p><p>The clinical syndrome epilepsy of infancy with migrating focal seizures (EIMFS) of all causes is itself rare. Prevalence of EIMFS was estimated at 0.11 per 100,000 children in the UK (using data that were not from a population-based epidemiologic study) [<a class="bk_pop" href="#slc12a5-e.REF.mctague.2013.1578">McTague et al 2013</a>].</p></div></div><div id="slc12a5-e.Genetically_Related_Allelic_Di"><h2 id="_slc12a5-e_Genetically_Related_Allelic_Di_">Genetically Related (Allelic) Disorders</h2><p>Heterozygous (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) parents of a child with <i>SLC12A5-</i>related epilepsy &#x02013; when tested &#x02013; were unaffected. Although <i>SLC12A5</i> pathogenic variants associated with EIMFS in general have not been associated with epilepsy in the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state, two possible exceptions are the following:</p><ul><li class="half_rhythm"><div><b>Possible association with febrile seizures.</b> The <i>SLC12A5</i> p.Arg952His variant was identified in an extended kindred with infrequent febrile seizures (1&#x02013;3 episodes on average) occurring between ages 12 months and 2.5 years. Only three of four <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members could be tested for the variant [<a class="bk_pop" href="#slc12a5-e.REF.puskarjov.2014.723">Puskarjov et al 2014</a>]. Although the mean <a class="def" href="/books/n/gene/glossary/def-item/allele-frequency/">allele frequency</a> in gnomAD in all populations is 0.003090, in South Asian populations the mean allele frequency is 0.01934. In addition, in gnomAD 13 unaffected individuals are identified as <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for this variant. Therefore, additional studies are needed to determine if <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> variants in <i>SLC12A5</i> are associated with febrile seizures.</div></li><li class="half_rhythm"><div><b>Possible association with <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a> generalized epilepsy.</b> While the rare <i>SLC12A5</i> variants p.Arg952His and p.Arg1049Cys were observed in controls, they were also enriched in a cohort of individuals with idiopathic generalized epilepsy (IGE) characterized by generalized tonic-clonic, myoclonic, and absence seizures [<a class="bk_pop" href="#slc12a5-e.REF.kahle.2014.766">Kahle et al 2014</a>]. Seizure onset was between 14 and 21 years. However, data are limited; additional studies are needed to determine if <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> variants in <i>SLC12A5</i> are associated with idiopathic generalized epilepsy.</div></li></ul></div><div id="slc12a5-e.Differential_Diagnosis"><h2 id="_slc12a5-e_Differential_Diagnosis_">Differential Diagnosis</h2><p>Since first described by <a class="bk_pop" href="#slc12a5-e.REF.coppola.1995.1017">Coppola et al [1995]</a>, epilepsy of infancy with migrating focal seizures (EIMFS) has been reported in over 170 individuals. EIMFS is genetically heterogeneous (<a class="figpopup" href="/books/NBK537476/table/slc12a5-e.T.other_disorders_to_consider/?report=objectonly" target="object" rid-figpopup="figslc12a5eTotherdisorderstoconsider" rid-ob="figobslc12a5eTotherdisorderstoconsider">Table 2</a>). EIMFS can be <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> or have multisystem involvement; both <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> and recessive inheritance are observed.</p><div id="slc12a5-e.T.other_disorders_to_consider" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Other Disorders to Consider in the Differential Diagnosis of <i>SLC12A5-</i>EIMFS</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK537476/table/slc12a5-e.T.other_disorders_to_consider/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__slc12a5-e.T.other_disorders_to_consider_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<b><sup>1</sup></b></th><th id="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comments</th></tr></thead><tbody><tr><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1 hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2 hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_3 hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Isolated EIMFS</b></td></tr><tr><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE43<br />(OMIM <a href="https://omim.org/entry/617113" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">617113</a>)</td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GABRB3</i>&#x000a0;<sup>2</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 set of monozygotic twins</td></tr><tr><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE14<br />(OMIM <a href="https://omim.org/entry/614959" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614959</a>)</td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>KCNT1</i></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>3</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Causes 30%-50% of EIMFS&#x000a0;<sup>4,&#x000a0;5,&#x000a0;6</sup></td></tr><tr><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE12<br />(OMIM <a href="https://omim.org/entry/613722" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613722</a>)</td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLCB1</i>&#x000a0;<sup>7</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR&#x000a0;<sup>8</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 individual&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Progressive microcephaly<br />w/seizures &#x00026; cerebral<br />&#x00026; cerebellar atrophy<br />(OMIM <a href="https://omim.org/entry/615760" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">615760</a>)</td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>QARS</i></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR&#x000a0;<sup>8</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 individuals&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMC1A</i>-related EIMFS</td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMC1A</i>&#x000a0;<sup>10</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 female infant</td></tr><tr><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/gefs/">EIEE6</a></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCN1A</i>&#x000a0;<sup>11,&#x000a0;12,&#x000a0;13,&#x000a0;14</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>3</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3 individuals&#x000a0;<sup>11,&#x000a0;12,&#x000a0;13,&#x000a0;14</sup></td></tr><tr><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE11<br />(OMIM <a href="https://omim.org/entry/613721" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">613721</a>)</td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCN2A</i>&#x000a0;<sup>15,&#x000a0;16</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>3</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe movement disorder&#x000a0;<sup>4</sup>; otherwise indistinguishable from other causes of EIMFS</td></tr><tr><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/scn8a-ee/">EIEE13</a></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SCN8A</i>&#x000a0;<sup>17</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>3</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1 individual&#x000a0;<sup>17</sup></td></tr><tr><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">EIEE3<br />(OMIM <a href="https://omim.org/entry/609304" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">609304</a>)</td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC25A22</i>&#x000a0;<sup>18</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR&#x000a0;<sup>8</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2 individuals&#x000a0;<sup>18</sup></td></tr><tr><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/tbc1d24-dis/">EIEE16</a></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TBC1D24</i>&#x000a0;<sup>19,&#x000a0;20</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR&#x000a0;<sup>8</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3 families&#x000a0;<sup>19,&#x000a0;20</sup></td></tr><tr><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1 hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2 hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_3 hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_4" colspan="4" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>EIMFS with multisystem abnormalities</b></td></tr><tr><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ALG3-CDG<br />(<i>CDG-Id</i>)&#x000a0;<sup>21</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALG</i>&#x000a0;<sup>22</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_4" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Abnormalities: gastrointestinal problems, coagulopathy, <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> facial features, spastic quadriparesis</div></li><li class="half_rhythm"><div>Transferrin <a class="def" href="/books/n/gene/glossary/def-item/isoelectric-focusing/">isoelectric focusing</a> testing consistent w/CDG type I</div></li><li class="half_rhythm"><div>On brain MRI: cerebellar atrophy in all; brain stem atrophy in 3/4</div></li><li class="half_rhythm"><div>Note: Extensive metabolic investigation in EIMFS is usually unrevealing.</div></li></ul></td></tr><tr><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ALG1-CDG<br />(<i>CDG-Ik</i>)&#x000a0;<sup>21</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALG1</i>&#x000a0;<sup>22</sup></td></tr><tr><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">RFT1-CDG<br />(<i>CDG-In</i>)&#x000a0;<sup>21</sup></td><td headers="hd_h_slc12a5-e.T.other_disorders_to_consider_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RFT1</i>&#x000a0;<sup>22</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Adapted from "Supplementary Table 1: Genes Reported in Migrating Partial Seizures of Infancy (MPSI)" [<a class="bk_pop" href="#slc12a5-e.REF.st_dberg.2015.8038">St&#x000f6;dberg et al 2015</a>]</p></div></dd><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; CDG = <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> disorder of glycosylation; EIEE = early-infantile epileptic encephalopathy; EIMFS = epilepsy of infancy with migrating focal seizures; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt>1. </dt><dd><div id="slc12a5-e.TF.2.1"><p class="no_margin">Genes are in alphabetic order.</p></div></dd><dt>2. </dt><dd><div id="slc12a5-e.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF._t_rbov_.2018.204">&#x00160;t&#x0011b;rbov&#x000e1; et al [2018]</a></p></div></dd><dt>3. </dt><dd><div id="slc12a5-e.TF.2.3"><p class="no_margin">Typically <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a></p></div></dd><dt>4. </dt><dd><div id="slc12a5-e.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.barcia.2012.1255">Barcia et al [2012]</a></p></div></dd><dt>5. </dt><dd><div id="slc12a5-e.TF.2.5"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.m_ller.2015.e114">M&#x000f8;ller et al [ 2015]</a></p></div></dd><dt>6. </dt><dd><div id="slc12a5-e.TF.2.6"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.lim.2016.217">Lim et al [2016]</a></p></div></dd><dt>7. </dt><dd><div id="slc12a5-e.TF.2.7"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.poduri.2012.e146">Poduri et al [2012]</a>, <a class="bk_pop" href="#slc12a5-e.REF.poduri.2013.873">Poduri et al [2013]</a></p></div></dd><dt>8. </dt><dd><div id="slc12a5-e.TF.2.8"><p class="no_margin">Autosomal recessive inheritance of EIMFS is often described in <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> families or families with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual.</p></div></dd><dt>9. </dt><dd><div id="slc12a5-e.TF.2.9"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.zhang.2014.547">Zhang et al [2014]</a></p></div></dd><dt>10. </dt><dd><div id="slc12a5-e.TF.2.10"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.gorman.2017.1301">Gorman et al [2017]</a></p></div></dd><dt>11. </dt><dd><div id="slc12a5-e.TF.2.11"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.carranza_rojo.2011.380">Carranza Rojo et al [2011]</a></p></div></dd><dt>12. </dt><dd><div id="slc12a5-e.TF.2.12"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.howell.2015.958">Howell et al [2015]</a></p></div></dd><dt>13. </dt><dd><div id="slc12a5-e.TF.2.13"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.larsen.2015.480">Larsen et al [2015]</a></p></div></dd><dt>14. </dt><dd><div id="slc12a5-e.TF.2.14"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.freilich.2011.665">Freilich et al [2011]</a></p></div></dd><dt>15. </dt><dd><div id="slc12a5-e.TF.2.15"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.howell.2015.958">Howell et al [2015]</a></p></div></dd><dt>16. </dt><dd><div id="slc12a5-e.TF.2.16"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.wolff.2017.1316">Wolff et al [2017]</a></p></div></dd><dt>17. </dt><dd><div id="slc12a5-e.TF.2.17"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.ohba.2014.994">Ohba et al [2014]</a></p></div></dd><dt>18. </dt><dd><div id="slc12a5-e.TF.2.18"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.poduri.2013.873">Poduri et al [2013]</a></p></div></dd><dt>19. </dt><dd><div id="slc12a5-e.TF.2.19"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.milh.2013.869">Milh et al [2013]</a></p></div></dd><dt>20. </dt><dd><div id="slc12a5-e.TF.2.20"><p class="no_margin">See <a href="/books/n/gene/tbc1d24-dis/"><i>TBC1D24</i>-Related Disorders</a>.</p></div></dd><dt>21. </dt><dd><div id="slc12a5-e.TF.2.21"><p class="no_margin">See <a href="/books/n/gene/cdg/">Congential Disorders of N-Linked Glycosylation and Multiple Pathway Overview</a>.</p></div></dd><dt>22. </dt><dd><div id="slc12a5-e.TF.2.22"><p class="no_margin"><a class="bk_pop" href="#slc12a5-e.REF.barba.2016.1085">Barba et al [2016]</a></p></div></dd></dl></div></div></div><p><b>Other early-infantile epileptic encephalopathies.</b> A large number of genes have been implicated in the broader <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of early-onset epilepsy with developmental delay. See <a href="http://omim.org/phenotypicSeries/PS308350" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Early Infantile Epileptic Encephalopathy, OMIM Phenotypic Series</a> to view genes associated with this phenotype in OMIM.</p></div><div id="slc12a5-e.Management"><h2 id="_slc12a5-e_Management_">Management</h2><div id="slc12a5-e.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>SLC12A5</i>-related epilepsy of infancy with migrating focal seizures (<i>SLC12A5</i>-EIMFS), the evaluations summarized in <a class="figpopup" href="/books/NBK537476/table/slc12a5-e.T.recommended_evaluations_foll/?report=objectonly" target="object" rid-figpopup="figslc12a5eTrecommendedevaluationsfoll" rid-ob="figobslc12a5eTrecommendedevaluationsfoll">Table 3</a> (if not performed as part of the evaluation that led to diagnosis) are recommended.</p><div id="slc12a5-e.T.recommended_evaluations_foll" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with <i>SLC12A5</i>-EIMFS</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK537476/table/slc12a5-e.T.recommended_evaluations_foll/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__slc12a5-e.T.recommended_evaluations_foll_lrgtbl__"><table><thead><tr><th id="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Constitutional</b></td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess for evidence of failure to thrive.</td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Eyes</b></td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation incl assessment of vision</td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>ENT/Mouth</b></td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assess hearing.</td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Gastrointestinal/</b><br /><b>Feeding</b></td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Assess swallowing, gastroesophageal reflux, feeding, &#x00026; nutritional status.</td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl assessment by speech &#x00026; language therapist.</td></tr><tr><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Assess respiratory status for evidence of &#x02191; risk of respiratory infections &#x00026; aspiration.</td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Preventive measures may be needed (e.g., flu vaccination &#x00026; prophylactic antibiotics in winter).</td></tr><tr><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic evaluation</td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl EEG &#x00026; brain MRI.</td></tr><tr><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment of tone by pediatric rehabilitation specialist &#x00026;/or physical therapist</td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Development</b></td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental assessment</td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl evaluation of motor skills, speech/language, general cognitive, &#x00026; vocational skills.</td></tr><tr><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_slc12a5-e.T.recommended_evaluations_foll_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div></div><div id="slc12a5-e.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Seizures.</b> There are no specific treatments for seizures in <i>SLC12A5</i>-EIMFS. Seizures in EIMFS are generally resistant to most antiepileptic drugs.</p><p>Periods free of seizures or with reduced seizure frequency have been achieved with a ketogenic diet or potassium bromides [<a class="bk_pop" href="#slc12a5-e.REF.fasulo.2012.182">Fasulo et al 2012</a>, <a class="bk_pop" href="#slc12a5-e.REF._nver.2013.355">&#x000dc;nver et al 2013</a>, <a class="bk_pop" href="#slc12a5-e.REF.caraballo.2014.899">Caraballo et al 2014</a>, <a class="bk_pop" href="#slc12a5-e.REF.caraballo.2015.194">Caraballo et al 2015</a>] including in children with <i>SLC12A5</i>-EIMFS [<a class="bk_pop" href="#slc12a5-e.REF.st_dberg.2015.8038">St&#x000f6;dberg et al 2015</a>, <a class="bk_pop" href="#slc12a5-e.REF.saitsu.2016.30072">Saitsu et al 2016</a>, <a class="bk_pop" href="#slc12a5-e.REF.saito.2017.654">Saito et al 2017</a>].</p><p>Seizure reduction has also been reported with:</p><ul><li class="half_rhythm"><div>Levetiracetam, rufinamide, stiripentol, and clonazepam [<a class="bk_pop" href="#slc12a5-e.REF.coppola.1995.1017">Coppola et al 1995</a>, <a class="bk_pop" href="#slc12a5-e.REF.cilio.2009.66">Cilio et al 2009</a>, <a class="bk_pop" href="#slc12a5-e.REF.djuric.2011.22">Djuric et al 2011</a>, <a class="bk_pop" href="#slc12a5-e.REF.vendrame.2011.18">Vendrame et al 2011</a>, <a class="bk_pop" href="#slc12a5-e.REF.merdariu.2013.177">Merdariu et al 2013</a>];</div></li><li class="half_rhythm"><div>Cannabinoids [<a class="bk_pop" href="#slc12a5-e.REF.saade.2015.544">Saade &#x00026; Joshi 2015</a>].</div></li></ul><p>Epileptic apneas are reported to respond to acetazolamide [<a class="bk_pop" href="#slc12a5-e.REF.irahara.2011.185">Irahara et al 2011</a>].</p><p>Education of parents regarding common seizure presentations is appropriate. For information on non-medical interventions and coping strategies for parents or caregivers of children diagnosed with epilepsy, see <a href="http://www.epilepsy.com/sites/core/files/atoms/files/English_Toolkit_updated%202014.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy &#x00026; My Child Toolkit</a>.</p><p><b>Hypotonia.</b> Manage postural problems with appropriate seating support.</p><p><b>Feeding.</b> Consider gastrostomy insertion and feeding if swallowing is impaired.</p><p><b>Respiratory.</b> Children may be susceptible to respiratory infections and aspiration pneumonia if swallowing is impaired. Consider influenza vaccine, prophylactic antibiotics, and chest physiotherapy as appropriate.</p><div id="slc12a5-e.Developmental_Disability__Inte"><h4>Developmental Disability / Intellectual Disability Management Issues</h4><p>The following information represents typical management recommendations for individuals with developmental delay / intellectual disability in the United States; standard recommendations may vary from country to country.</p><p><b>Ages 0-3 years.</b> Referral to an early intervention program is recommended for access to occupational, physical, speech, and feeding therapy. In the US, early intervention is a federally funded program available in all states.</p><p><b>Ages 3-5 years.</b> In the US, developmental preschool through the local public school district is recommended. Before placement, an evaluation is made to determine needed services and therapies and an individualized education plan (IEP) is developed.</p><p><b>Ages 5-21 years</b></p><ul><li class="half_rhythm"><div>In the US, an IEP based on the individual's level of function should be developed by the local public school district. Affected children are permitted to remain in the public school district until age 21.</div></li><li class="half_rhythm"><div>Discussion of transition plans including financial, vocation/employment, and medical arrangements should begin at age 12 years. Developmental pediatricians can provide assistance with transition to adulthood.</div></li></ul><p><b>All ages.</b> Consultation with a developmental pediatrician is recommended to ensure the involvement of appropriate community, state, and educational agencies and to support parents in maximizing quality of life.</p><p>Consideration of private supportive therapies based on the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's needs is recommended. Specific recommendations regarding type of therapy can be made by a developmental pediatrician.</p><p>In the US:</p><ul><li class="half_rhythm"><div>Developmental Disabilities Administration (DDA) enrollment is recommended. DDA is a public agency that provides services and support to qualified individuals. Eligibility differs by state but is typically determined by diagnosis and/or associated cognitive/adaptive disabilities.</div></li><li class="half_rhythm"><div>Families with limited income and resources may also qualify for supplemental security income (SSI) for their child with a disability.</div></li></ul></div><div id="slc12a5-e.Motor_Dysfunction"><h4>Motor Dysfunction</h4><p><b>Gross motor dysfunction</b></p><ul><li class="half_rhythm"><div>Physical therapy is recommended to maximize mobility.</div></li><li class="half_rhythm"><div>Consider use of durable medical equipment as needed (e.g., wheelchairs, walkers, bath chairs, orthotics, adaptive strollers).</div></li></ul><p><b>Fine motor dysfunction.</b> Occupational therapy is recommended for difficulty with fine motor skills that affect adaptive function such as feeding, grooming, dressing, and writing.</p><p><b>Oral motor dysfunction.</b> Assuming that the individual is safe to eat by mouth, feeding therapy, typically from an occupational or speech therapist is recommended for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who have difficulty feeding due to poor oral motor control.</p><p><b>Communication issues.</b> Consider evaluation for alternative means of communication (e.g., <a href="http://www.asha.org/NJC/AAC/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Augmentative and Alternative Communication</a> [AAC]) for individuals who have expressive language difficulties.</p></div><div id="slc12a5-e.SocialBehavioralConcerns"><h4>Social/BehavioralConcerns</h4><p>Children may qualify for and benefit from interventions used in treatment of autism spectrum disorder, including applied behavior analysis (ABA). ABA therapy is targeted to the individual child's behavioral, social, and adaptive strengths and weaknesses and is typically performed one on one with a board-certified behavior analyst.</p><p>Consultation with a developmental pediatrician may be helpful in guiding parents through appropriate behavior management strategies or providing prescription medications, such as medication used to treat attention-deficit/hyperactivity disorder, when necessary.</p><p>Concerns about serious aggressive or destructive behavior can be addressed by a pediatric psychiatrist.</p></div></div><div id="slc12a5-e.Surveillance"><h3>Surveillance</h3><p>Routine monitoring of:</p><ul><li class="half_rhythm"><div>Feeding, nutritional status, swallowing abilities, gastroesophageal reflux, risk of aspiration pneumonia / respiratory infection</div></li><li class="half_rhythm"><div>Postural problems (resulting from such complications as scoliosis and hip abnormalities) with regular spine and hip x-rays</div></li><li class="half_rhythm"><div>Effectiveness of seizure control</div></li><li class="half_rhythm"><div>Development including motor skills, speech/language, and general cognitive and vocational skills</div></li></ul></div><div id="slc12a5-e.Evaluation_of_Relatives_at_Ris"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#slc12a5-e.Related_Genetic_Counseling_Iss">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="slc12a5-e.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="slc12a5-e.Genetic_Counseling"><h2 id="_slc12a5-e_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="slc12a5-e.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>SLC12A5</i>-related epilepsy of infancy with migrating focal seizures (<i>SLC12A5</i>-EIMFS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="slc12a5-e.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of a child with <i>SLC12A5</i>-EIMFS are typically heterozygotes (i.e., carriers of one <i>SLC12A5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>). In a one family reported to date, a <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> was found to have one maternally inherited <i>SLC12A5</i> pathogenic variant and one <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> variant (the father was not a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>SLC12A5</i> pathogenic variant) [<a class="bk_pop" href="#slc12a5-e.REF.saito.2017.654">Saito et al 2017</a>].</div></li></ul><ul><li class="half_rhythm"><div>Heterozygous parents of a child with <i>SLC12A5</i>-EIMFS are not at risk of developing EIMFS. (<i>SLC12A5</i> pathogenic variants associated with EIMFS have not been associated with epilepsy in the <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> state; see <a href="#slc12a5-e.Genetically_Related_Allelic_Di">Genetically Related Disorders</a>).</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) of an EIMFS-related <i>SLC12A5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are not at risk of developing EIMFS.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with <i>SLC12A5</i>-EIMFS has a 50% chance of inheriting the <i>SLC12A5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>To date, individuals with <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> <i>SLC12A5</i>-EIMFS are not known to reproduce.</div></li></ul><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>SLC12A5</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="slc12a5-e.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>SLC12A5</i> pathogenic variants in the family.</p></div><div id="slc12a5-e.Related_Genetic_Counseling_Iss"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><p>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</p><p>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to parents of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals and young adults who are carriers or are at risk of being carriers.</p><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="slc12a5-e.Prenatal_Testing_and_Preimplan"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SLC12A5</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="slc12a5-e.Resources"><h2 id="_slc12a5-e_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>American Epilepsy Society (AES)</b></div><div><a href="http://www.aesnet.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.aesnet.org</a></div></li><li class="half_rhythm"><div><b>Canadian Epilepsy Alliance</b></div><div>Canada</div><div><b>Phone:</b> 1-866-EPILEPSY (1-866-374-5377)</div><div><a href="http://epilepsymatters.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsymatters.com</a></div></li><li class="half_rhythm"><div><b>Contact a Family</b></div><div>209-211 City Road</div><div>London EC1V 1JN</div><div>United Kingdom</div><div><b>Phone:</b> 0808 808 3555 (toll free); 020 7608 8700</div><div><b>Email:</b> helpline@cafamily.org.uk</div><div><a href="http://www.cafamily.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.cafamily.org.uk</a></div></li><li class="half_rhythm"><div><b>Epilepsy Action</b></div><div>New Anstey House</div><div>Gate Way Drive</div><div>Yeadon Leeds LS19 7XY</div><div>United Kingdom</div><div><b>Phone:</b> 0808 800 5050</div><div><b>Email:</b> epilepsy@epilepsy.org.uk</div><div><a href="https://www.epilepsy.org.uk/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.org.uk</a></div></li><li class="half_rhythm"><div><b>Epilepsy Canada</b></div><div>Canada</div><div><b>Phone:</b> 877-734-0873</div><div><b>Email:</b> epilepsy@epilepsy.ca</div><div><a href="http://www.epilepsy.ca/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.ca</a></div></li><li class="half_rhythm"><div><b>Epilepsy Foundation</b></div><div>8301 Professional Place East</div><div>Suite 200</div><div>Landover MD 20785-7223</div><div><b>Phone:</b> 800-332-1000 (toll-free)</div><div><b>Email:</b> ContactUs@efa.org</div><div><a href="https://www.epilepsy.com/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.epilepsy.com</a></div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="http://www.ninds.nih.gov/disorders/epilepsy/epilepsy.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Epilepsy Information Page</a></div></li></ul></div><div id="slc12a5-e.Molecular_Genetics"><h2 id="_slc12a5-e_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="slc12a5-e.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>SLC12A5-Related Epilepsy of Infancy with Migrating Focal Seizures: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK537476/table/slc12a5-e.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__slc12a5-e.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_slc12a5-e.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_slc12a5-e.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_slc12a5-e.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_slc12a5-e.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_slc12a5-e.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_slc12a5-e.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/57468" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SLC12A5</i></a></td><td headers="hd_b_slc12a5-e.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=57468" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">20q13<wbr style="display:inline-block"></wbr>​.12</a></td><td headers="hd_b_slc12a5-e.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q9H2X9" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Solute carrier family 12 member 5</a></td><td headers="hd_b_slc12a5-e.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SLC12A5" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC12A5</a></td><td headers="hd_b_slc12a5-e.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SLC12A5[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC12A5</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="slc12a5-e.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="slc12a5-e.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for SLC12A5-Related Epilepsy of Infancy with Migrating Focal Seizures (<a href="/omim/606726,616645" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK537476/table/slc12a5-e.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__slc12a5-e.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606726" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606726</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER 5; SLC12A5</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/616645" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">616645</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34</td></tr></tbody></table></div></div><div id="slc12a5-e.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><i>SLC12A5</i> encodes KCC2, the neuronal-specific potassium chloride co-transporter which is a member of the family of cation chloride co-transporters [<a class="bk_pop" href="#slc12a5-e.REF.payne.1996.16245">Payne et al 1996</a>]. KCC2 is mainly expressed in the central nervous system [<a class="bk_pop" href="#slc12a5-e.REF.chamma.2012.5">Chamma et al 2012</a>].</p><p>KCC2 is the major extruder of chloride in neurons and is responsible for generating neuronal chloride gradients, which determine the magnitude and polarity of GABA-mediated currents. Thus, when GABA, which has an important role in neuronal inhibition, binds to the GABA-A receptor, the low intraneuronal chloride allows influx of chloride and subsequent hyperpolarization, contributing to neuronal inhibition. KCC2 has been implicated as the major factor in the developmental GABA<sub>A</sub> shift from excitation to inhibition seen in early postnatal life in animal models and is vital to normal brain development [<a class="bk_pop" href="#slc12a5-e.REF.chamma.2012.5">Chamma et al 2012</a>].</p><p><b>Gene structure.</b>
<i>SLC12A5</i> has two major neuron-specific <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>, KCC2a (corresponding to transcript variant 1, NM_001134771) and the shorter KCC2b (transcript variant 2, NM_020708) [<a class="bk_pop" href="#slc12a5-e.REF.uvarov.2007.30570">Uvarov et al 2007</a>, <a class="bk_pop" href="#slc12a5-e.REF.uvarov.2009.13696">2009</a>], both containing 26 exons. KCC2a differs from KCC2b by 40 unique amino acids in the N terminus encoded by alternate <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1a.</p><p><b>Pathogenic variants.</b> Pathogenic variants identified to date are mostly <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants; however, a few <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> and <a class="def" href="/books/n/gene/glossary/def-item/in-frame/">in-frame</a> variants have been reported.</p><div id="slc12a5-e.T.selected_slc12a5_pathogenic" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Selected <i>SLC12A5</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK537476/table/slc12a5-e.T.selected_slc12a5_pathogenic/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__slc12a5-e.T.selected_slc12a5_pathogenic_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.279+1G&#x0003e;C</td><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Glu50_Gln93del</td><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_3" rowspan="11" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_020708.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_020708<wbr style="display:inline-block"></wbr>​.4</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_065759" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP<wbr style="display:inline-block"></wbr>​_065759</a></td></tr><tr><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.572C&#x0003e;T</td><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg191Val</td></tr><tr><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.863T&#x0003e;A<br />(c.932T&#x0003e;A)&#x000a0;<sup>1</sup></td><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu288His<br />(p.Leu311His)&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">c.953G&#x0003e;C</td><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Trp318Ser</td></tr><tr><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.967T&#x0003e;C</td><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser323Pro</td></tr><tr><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1127C&#x0003e;T<br />(c.1196C&#x0003e;T)&#x000a0;<sup>1</sup></td><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser376Leu<br />(p.Ser399Leu)&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1208T&#x0003e;C<br />(c.1277T&#x0003e;C)&#x000a0;<sup>1</sup></td><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Leu403Pro<br />(p.Leu426Pro)&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1243A&#x0003e;G</td><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met415Val</td></tr><tr><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1583G&#x0003e;A<br />(c.1652G&#x0003e;A)&#x000a0;<sup>1</sup></td><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly528Asp<br />(p.Gly551Asp)&#x000a0;<sup>1</sup></td></tr><tr><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2242_2244del</td><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser748del</td></tr><tr><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2570G&#x0003e;T<br />(c.2639G&#x0003e;T)&#x000a0;<sup>1</sup></td><td headers="hd_h_slc12a5-e.T.selected_slc12a5_pathogenic_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg857Leu<br />(p.Arg880Leu)&#x000a0;<sup>1</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="slc12a5-e.TF.4.1"><p class="no_margin">Variant designation as published on reference sequence position <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001134771.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001134771<wbr style="display:inline-block"></wbr>​.1</a>, <a href="https://www.ncbi.nlm.nih.gov/protein/NP_001128243.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001128243<wbr style="display:inline-block"></wbr>​.1</a></p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SLC12A5</i> encodes KCC2, the neuronal-specific potassium chloride co-transporter, a member of the family of cation chloride co-transporters [<a class="bk_pop" href="#slc12a5-e.REF.payne.1996.16245">Payne et al 1996</a>]. KCC2 is mainly expressed in the central nervous system [<a class="bk_pop" href="#slc12a5-e.REF.chamma.2012.5">Chamma et al 2012</a>]. The two major <i>SLC12A5</i> transcripts KCC2a (corresponding to NM_001134771) and KCC2b (NM_020708) comprise 26 exons and are translated into 1,139 and 1,116 amino acids, respectively.</p><p>KCC2 also plays a role at excitatory synapses and in dendritic spine formation [<a class="bk_pop" href="#slc12a5-e.REF.chamma.2012.5">Chamma et al 2012</a>, <a class="bk_pop" href="#slc12a5-e.REF.puskarjov.2014.723">Puskarjov et al 2014</a>]. Further evidence for the role of KCC2 in epileptogenesis comes from animal models of acquired epilepsy in which reduced KCC2 expression is seen following status epilepticus, and from human studies in which tumor-associated epilepsy is associated with alterations in KCC2 expression [<a class="bk_pop" href="#slc12a5-e.REF.pallud.2014.244ra89">Pallud et al 2014</a>, <a class="bk_pop" href="#slc12a5-e.REF.moore.2017.555">Moore et al 2017</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>SLC12A5</i> pathogenic variants have been shown in several studies to be associated with a loss of transporter function in cellular models [<a class="bk_pop" href="#slc12a5-e.REF.st_dberg.2015.8038">St&#x000f6;dberg et al 2015</a>, <a class="bk_pop" href="#slc12a5-e.REF.saitsu.2016.30072">Saitsu et al 2016</a>].</p><p>The variants p.Arg952His and p.Arg1049Cys have also been studied for pathogenic effects. (See <a href="#slc12a5-e.Genetically_Related_Allelic_Di">Genetically Related Disorders</a>.)</p><p>The p.Arg952His variant was shown to have reduced cell surface expression and reduced chloride extrusion capacity compared to wild type KCC2 [<a class="bk_pop" href="#slc12a5-e.REF.kahle.2014.766">Kahle et al 2014</a>, <a class="bk_pop" href="#slc12a5-e.REF.puskarjov.2014.723">Puskarjov et al 2014</a>]. In addition, p.Arg952His led to reduced dendritic spine formation in vitro, which could be rescued by overexpression of wild type KCC2.</p><p>The p.Arg1049Cys variant was shown to have decreased chloride extrusion ability [<a class="bk_pop" href="#slc12a5-e.REF.kahle.2014.766">Kahle et al 2014</a>].</p><p>Both p.Arg952His and p.Arg1049Cys were also shown to have decreased phosphorylation at serine 940, a key site for the regulation of KCC2 function [<a class="bk_pop" href="#slc12a5-e.REF.kahle.2014.766">Kahle et al 2014</a>].</p><p>Complete knockout of <i>SLC12A5</i> in animal models leads to neonatal death due to respiratory failure, and knockout of the KCC2b isoform only leads to spontaneous seizures and early postnatal mortality [<a class="bk_pop" href="#slc12a5-e.REF.h_bner.2001.515">H&#x000fc;bner et al 2001</a>, <a class="bk_pop" href="#slc12a5-e.REF.woo.2002.258">Woo et al 2002</a>, <a class="bk_pop" href="#slc12a5-e.REF.tornberg.2005.1327">Tornberg et al 2005</a>].</p></div></div><div id="slc12a5-e.References"><h2 id="_slc12a5-e_References_">References</h2><div id="slc12a5-e.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.barba.2016.1085">Barba C, Darra F, Cusmai R, Procopio E, Dionisi Vici C, Keldermans L, Vuillaumier-Barrot S, Lefeber DJ, Guerrini R, Parrini E, Ashikov A, Bordugo A, Cantalupo G, Casara G, Bernardina BD, Falchi M, Ferri L, Martinelli D, Morrone A, Race V, Rosati A, Souche E. Congenital disorders of glycosylation presenting as epileptic encephalopathy with migrating partial seizures in infancy. <span><span class="ref-journal">Dev Med Child Neurol. </span>2016;<span class="ref-vol">58</span>:1085–91.</span> [<a href="/pubmed/27172925" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27172925</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.barcia.2012.1255">Barcia G, Fleming M. R, Deligniere A, Gazula VR, Brown MR, Langouet M, Chen H, Kronengold J, Abhyankar A, Cilio R, Nitschke P, Kaminska A, Boddaert N, Casanova JL, Desguerre I, Munnich A, Dulac O, Kaczmarek LK, Colleaux L, Nabbout R. De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:1255–9.</span> [<a href="/pmc/articles/PMC3687547/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3687547</span></a>] [<a href="/pubmed/23086397" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23086397</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.caraballo.2015.194">Caraballo R, Noli D, Cachia P. Epilepsy of infancy with migrating focal seizures: three patients treated with the ketogenic diet. <span><span class="ref-journal">Epileptic Disord. </span>2015;<span class="ref-vol">17</span>:194–7.</span> [<a href="/pubmed/25895661" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25895661</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.caraballo.2014.899">Caraballo R, Pasteris MC, Fortini PS, Portuondo E. Epilepsy of infancy with migrating focal seizures: six patients treated with bromide. <span><span class="ref-journal">Seizure. </span>2014;<span class="ref-vol">23</span>:899–902.</span> [<a href="/pubmed/25044045" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25044045</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.carranza_rojo.2011.380">Carranza Rojo D, Hamiwka L, McMahon JM, Dibbens LM, Arsov T, Suls A, St&#x000f6;dberg T, Kelley K, Wirrell E, Appleton B, MacKay M, Freeman JL, Yendle SC, Berkovic SF, Bienvenu T, De Jonghe P, Thorburn DR, Mulley JC, Mefford HC, Scheffer IE. De novo SCN1A mutations in migrating partial seizures of infancy. <span><span class="ref-journal">Neurology. </span>2011;<span class="ref-vol">77</span>:380–3.</span> [<a href="/pmc/articles/PMC3140798/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3140798</span></a>] [<a href="/pubmed/21753172" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21753172</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.chamma.2012.5">Chamma I, Chevy Q, Poncer JC, L&#x000e9;vi S. Role of the neuronal K-Cl co-transporter KCC2 in inhibitory and excitatory neurotransmission. <span><span class="ref-journal">Front Cell Neurosci. </span>2012;<span class="ref-vol">6</span>:5.</span> [<a href="/pmc/articles/PMC3282916/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3282916</span></a>] [<a href="/pubmed/22363264" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22363264</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.cilio.2009.66">Cilio MR, Bianchi R, Balestri M, Onofri A, Giovannini S, Di Capua M, Vigevano F. Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy. <span><span class="ref-journal">Epilepsy Res. </span>2009;<span class="ref-vol">86</span>:66–71.</span> [<a href="/pubmed/19520548" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19520548</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.coppola.1995.1017">Coppola G, Plouin P, Chiron C, Robain O, Dulac O. Migrating partial seizures in infancy: a malignant disorder with developmental arrest. <span><span class="ref-journal">Epilepsia. </span>1995;<span class="ref-vol">36</span>:1017–24.</span> [<a href="/pubmed/7555952" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7555952</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.djuric.2011.22">Djuric M, Kravljanac R, Kovacevic G, Martic J. The efficacy of bromides, stiripentol and levetiracetam in two patients with malignant migrating partial seizures in infancy. <span><span class="ref-journal">Epileptic Disord. </span>2011;<span class="ref-vol">13</span>:22–6.</span> [<a href="/pubmed/21393091" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21393091</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.fasulo.2012.182">Fasulo L, Saucedo S, C&#x000e1;ceres L, Solis S, Caraballo R. Migrating focal seizures during infancy: a case report and pathologic study. <span><span class="ref-journal">Pediatr Neurol. </span>2012;<span class="ref-vol">46</span>:182–4.</span> [<a href="/pubmed/22353295" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22353295</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.freilich.2011.665">Freilich ER, Jones JM, Gaillard WD, Conry JA, Tsuchida TN, Reyes C, Dib-Hajj S, Waxman SG, Meisler MH, Pearl PL. Novel SCN1A mutation in a proband with malignant migrating partial seizures of infancy. <span><span class="ref-journal">Arch Neurol. </span>2011;<span class="ref-vol">68</span>:665–71.</span> [<a href="/pmc/articles/PMC3092158/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3092158</span></a>] [<a href="/pubmed/21555645" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21555645</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.gorman.2017.1301">Gorman KM, Forman E, Conroy J, Allen NM, Shahwan A, Lynch SA, Ennis S, King MD. Novel SMC1A variant and epilepsy of infancy with migrating focal seizures: expansion of the phenotype. <span><span class="ref-journal">Epilepsia. </span>2017;<span class="ref-vol">58</span>:1301–2.</span> [<a href="/pubmed/28677859" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28677859</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.howell.2015.958">Howell KB, McMahon JM, Carvill GL, Tambunan D, Mackay MT, Rodriguez-Casero V, Webster R, Clark D, Freeman JL, Calvert S, Olson HE, Mandelstam S, Poduri A, Mefford HC, Harvey AS, Scheffer IE. SCN2A encephalopathy: a major cause of epilepsy of infancy with migrating focal seizures. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">85</span>:958–66.</span> [<a href="/pmc/articles/PMC4567464/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4567464</span></a>] [<a href="/pubmed/26291284" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26291284</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.h_bner.2001.515">H&#x000fc;bner CA, Stein V, Hermans-Borgmeyer I, Meyer T, Ballanyi K, Jentsch TJ. Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition. <span><span class="ref-journal">Neuron. </span>2001;<span class="ref-vol">30</span>:515–24.</span> [<a href="/pubmed/11395011" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11395011</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.irahara.2011.185">Irahara K, Saito Y, Sugai K, Nakagawa E, Saito T, Komaki H, Nabatame S, Kaneko Y, Hotate M, Sasaki M. Effects of acetazolamide on epileptic apnea in migrating partial seizures in infancy. <span><span class="ref-journal">Epilepsy Res. </span>2011;<span class="ref-vol">96</span>:185–9.</span> [<a href="/pubmed/21636251" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21636251</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.kahle.2014.766">Kahle KT, Merner ND, Friedel P, Silayeva L, Liang B, Khanna A, Shang Y, Lachance-Touchette P, Bourassa C, Levert A, Dion P, Walcott B, Spiegelman D, Dionne-Laporte A, Hodgkinson A, Awadalla P, Nikbakht H, Majewski J, Cossette P, Deeb TZ, Moss SJ, Medina I, Rouleau G. Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsy. <span><span class="ref-journal">EMBO Rep. </span>2014;<span class="ref-vol">15</span>:766–74.</span> [<a href="/pmc/articles/PMC4196980/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4196980</span></a>] [<a href="/pubmed/24928908" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24928908</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.larsen.2015.480">Larsen J, Carvill GL, Depienne C, Brilstra E, Erik J, Nielsen K, Goldman R, Jepsen B, McMahon JM, Koeleman B, Harris M. The phenotypic spectrum of SCN8A encephalopathy. <span><span class="ref-journal">Neurology. </span>2015;<span class="ref-vol">84</span>:480–9.</span> [<a href="/pmc/articles/PMC4336074/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4336074</span></a>] [<a href="/pubmed/25568300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25568300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.lim.2016.217">Lim CX, Ricos MG, Dibbens LM, Heron SE. KCNT1 mutations in seizure disorders: the phenotypic spectrum and functional effects. <span><span class="ref-journal">J Med Genet. </span>2016;<span class="ref-vol">53</span>:217–25.</span> [<a href="/pubmed/26740507" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26740507</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.mctague.2013.1578">McTague A, Appleton R, Avula S, Cross JH, King MD, Jacques TS, Bhate S, Cronin A, Curran A, Desurkar A, Farrell MA, Hughes E, Jefferson R, Lascelles K, Livingston J, Meyer E, McLellan A, Poduri A, Scheffer IE, Spinty S, Kurian MA, Kneen R. Migrating partial seizures of infancy: expansion of the electroclinical, radiological and pathological disease spectrum. <span><span class="ref-journal">Brain. </span>2013;<span class="ref-vol">136</span>:1578–91.</span> [<a href="/pmc/articles/PMC3634200/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3634200</span></a>] [<a href="/pubmed/23599387" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23599387</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.mctague.2016.304">McTague A, Howell KB, Cross JH, Kurian MA, Scheffer IE. The genetic landscape of the epileptic encephalopathies of infancy and childhood. <span><span class="ref-journal">Lancet Neurol. </span>2016;<span class="ref-vol">15</span>:304–16.</span> [<a href="/pubmed/26597089" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26597089</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.mctague.2018.e55">McTague A, Nair U, Malhotra S, Meyer E, Trump N, Gazina EV, Papandreou A, Ngoh A, Ackermann S, Ambegaonkar G, Appleton R, Desurkar A, Eltze C, Kneen R, Kumar AV, Lascelles K, Montgomery T, Ramesh V, Samanta R, Scott RH, Tan J, Whitehouse W, Poduri A, Scheffer IE, Chong WK, Cross JH, Topf M, Petrou S, Kurian MA. Clinical and molecular characterisation of KCNT1-related severe early onset epilepsy. <span><span class="ref-journal">Neurology. </span>2018;<span class="ref-vol">90</span>:e55–e66.</span> [<a href="/pmc/articles/PMC5754647/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5754647</span></a>] [<a href="/pubmed/29196579" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29196579</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.merdariu.2013.177">Merdariu D, Delano&#x000eb; C, Mahfoufi N, Bellavoine V, Auvin S. Malignant migrating partial seizures of infancy controlled by stiripentol and clonazepam. <span><span class="ref-journal">Brain Dev. </span>2013;<span class="ref-vol">35</span>:177–80.</span> [<a href="/pubmed/22521903" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22521903</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.milh.2013.869">Milh M, Falace A, Villeneuve N, Vanni N, Cacciagli P, Assereto S, Nabbout R, Benfenati F, Zara F, Chabrol B, Villard L, Fassio A. Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy. <span><span class="ref-journal">Hum Mut. </span>2013;<span class="ref-vol">34</span>:869–72.</span> [<a href="/pubmed/23526554" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23526554</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.m_ller.2015.e114">M&#x000f8;ller RS, Heron SE, Larsen LHG, Lim CX, Ricos MG, Bayly MA, van Kempen MJA, Klinkenberg S, Andrews I, Kelley K, Ronen GM, Callen D, McMahon JM, Yendle SC, Carvill GL, Mefford HC, Nabbout R, Poduri A, Striano P, Baglietto MG, Zara F, Smith NJ, Pridmore C, Gardella E, Nikanorova M, Dahl HA, Gellert P, Scheffer IE, Gunning B, Kragh-Olsen B, Dibbens LM. Mutations in KCNT1 cause a spectrum of focal epilepsies. <span><span class="ref-journal">Epilepsia. </span>2015;<span class="ref-vol">56</span>:e114–20.</span> [<a href="/pmc/articles/PMC5915334/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5915334</span></a>] [<a href="/pubmed/26122718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26122718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.moore.2017.555">Moore YE, Kelley MR, Brandon NJ, Deeb TZ, Moss SJ. Seizing control of KCC2: a new therapeutic target for epilepsy. <span><span class="ref-journal">Trends Neurosci. </span>2017;<span class="ref-vol">40</span>:555–71.</span> [<a href="/pubmed/28803659" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28803659</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.ohba.2014.994">Ohba C, Kato M, Takahashi S, Lerman-Sagie T, Lev D, Terashima H, Kubota M, Kawawaki H, Matsufuji M, Kojima Y, Tateno A, Goldberg-Stern H, Straussberg R, Marom D, Leshinsky-Silver E, Nakashima M, Nishiyama K, Tsurusaki Y, Miyake N, Tanaka F, Matsumoto N, Saitsu H. Early onset epileptic encephalopathy caused by de novo SCN8A mutations. <span><span class="ref-journal">Epilepsia. </span>2014;<span class="ref-vol">55</span>:994–1000.</span> [<a href="/pubmed/24888894" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24888894</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.pallud.2014.244ra89">Pallud J, Le Van Quyen M, Bielle F, Pellegrino C, Varlet P, Labussiere M, Cresto N, Dieme MJ, Baulac M, Duyckaerts C, Kourdougli N, Chazal G, Devaux B, Rivera C, Miles R, Capelle L, Huberfeld G. Cortical GABAergic excitation contributes to epileptic activities around human glioma. <span><span class="ref-journal">Sci Transl Med. </span>2014;<span class="ref-vol">6</span>:244ra89.</span> [<a href="/pmc/articles/PMC4409113/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4409113</span></a>] [<a href="/pubmed/25009229" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25009229</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.payne.1996.16245">Payne JA, Stevenson TJ, Donaldson LF. Molecular characterization of a putative K-Cl cotransporter in rat brain: a neuronal-specific isoform. <span><span class="ref-journal">J Biol Chem. </span>1996;<span class="ref-vol">271</span>:16245–52.</span> [<a href="/pubmed/8663311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8663311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.poduri.2012.e146">Poduri A, Chopra SS, Neilan EG, Christina Elhosary P, Kurian MA, Meyer E, Barry BJ, Khwaja OS, Salih MA, St&#x000f6;dberg T, Scheffer IE, Maher ER, Sahin M, Wu BL, Berry GT, Walsh CA, Picker J, Kothare SV. Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy. <span><span class="ref-journal">Epilepsia. </span>2012;<span class="ref-vol">53</span>:e146–150.</span> [<a href="/pmc/articles/PMC3851296/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3851296</span></a>] [<a href="/pubmed/22690784" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22690784</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.poduri.2013.873">Poduri A, Heinzen EL, Chitsazzadeh V, Lasorsa FM, Elhosary PC, Lacoursiere CM, Martin E, Yuskaitis CJ, Hill RS, Atabay KD, Barry B, Partlow JN, Bashiri FA, Zeidan RM, Elmalik SA, Kabiraj MMU, Kothare S, St&#x000f6;dberg T, McTague A, Kurian MA, Scheffer IE, Barkovich AJ, Palmieri F, Salih MA, Walsh CA. SLC25A22 is a novel gene for migrating partial seizures in infancy. <span><span class="ref-journal">Ann Neurol. </span>2013;<span class="ref-vol">74</span>:873–82.</span> [<a href="/pmc/articles/PMC4031329/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4031329</span></a>] [<a href="/pubmed/24596948" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24596948</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.puskarjov.2014.723">Puskarjov M, Seja P, Heron SE, Williams TC, Ahmad F, Iona X, Oliver KL, Grinton BE, Vutskits L, Scheffer IE, Petrou S, Blaesse P, Dibbens LM, Berkovic SF, Kaila K. A variant of KCC2 from patients with febrile seizures impairs neuronal Cl- extrusion and dendritic spine formation. <span><span class="ref-journal">EMBO Rep. </span>2014;<span class="ref-vol">15</span>:723–9.</span> [<a href="/pmc/articles/PMC4197883/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4197883</span></a>] [<a href="/pubmed/24668262" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24668262</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.saade.2015.544">Saade D, Joshi C. Pure cannabidiol in the treatment of malignant migrating partial seizures in infancy: a case report. <span><span class="ref-journal">Pediatr Neurol. </span>2015;<span class="ref-vol">52</span>:544–7.</span> [<a href="/pubmed/25882081" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25882081</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.saito.2017.654">Saito T, Ishii A, Sugai K, Sasaki M, Hirose S. A de novo missense mutation in SLC12A5 found in a compound heterozygote patient with epilepsy of infancy with migrating focal seizures. <span><span class="ref-journal">Clin Genet. </span>2017;<span class="ref-vol">92</span>:654–8.</span> [<a href="/pubmed/28477354" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28477354</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.saitsu.2016.30072">Saitsu H, Watanabe M, Akita T, Ohba C, Sugai K, Ong WP, Shiraishi H, Yuasa S, Matsumoto H, Beng KT, Saitoh S, Miyatake S, Nakashima M, Miyake N, Kato M, Fukuda A, Matsumoto N. Impaired neuronal KCC2 function by biallelic SLC12A5 mutations in migrating focal seizures and severe developmental delay. <span><span class="ref-journal">Sci Rep. </span>2016;<span class="ref-vol">6</span>:30072.</span> [<a href="/pmc/articles/PMC4951812/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4951812</span></a>] [<a href="/pubmed/27436767" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27436767</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF._t_rbov_.2018.204">&#x00160;t&#x0011b;rbov&#x000e1; K, Vl&#x0010d;kov&#x000e1; M, Klement P, Neupauerov&#x000e1; J, Stan&#x0011b;k D, Z&#x0016f;nov&#x000e1; H, Seeman P, La&#x00161;&#x00161;uthov&#x000e1; P. Neonatal onset of epilepsy of infancy with migrating focal seizures associated with a novel GABRB3 variant in monozygotic twins. <span><span class="ref-journal">Neuropediatrics. </span>2018;<span class="ref-vol">49</span>:204–8.</span> [<a href="/pubmed/29444535" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29444535</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.st_dberg.2015.8038">St&#x000f6;dberg T, McTague A, Ruiz AJ, Hirata H, Zhen J, Long P, Farabella I, Meyer E, Kawahara A, Vassallo G, Stivaros SM, Bjursell MK, Stranneheim H, Tigerschi&#x000f6;ld S, Persson B, Bangash I, Das K, Hughes D, Lesko N, Lundeberg J, Scott RC, Poduri A, Scheffer IE, Smith H, Gissen P, Schorge S, Reith MEA, Topf M, Kullmann DM, Harvey RJ, Wedell A, Kurian MA. Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures. <span><span class="ref-journal">Nat Commun. </span>2015;<span class="ref-vol">6</span>:8038.</span> [<a href="/pmc/articles/PMC4569694/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4569694</span></a>] [<a href="/pubmed/26333769" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26333769</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.tornberg.2005.1327">Tornberg J, Voikar V, Savilahti H, Rauvala H, Airaksinen MS. Behavioural phenotypes of hypomorphic KCC2-deficient mice. <span><span class="ref-journal">Eur J Neurosci. </span>2005;<span class="ref-vol">21</span>:1327–37.</span> [<a href="/pubmed/15813942" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15813942</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF._nver.2013.355">&#x000dc;nver O, Incecik F, D&#x000fc;ndar H, K&#x000f6;m&#x000fc;r M, &#x000dc;nver A, Okuyaz &#x000c7;. Potassium bromide for treatment of malignant migrating partial seizures in infancy. <span><span class="ref-journal">Pediatr Neurol. </span>2013;<span class="ref-vol">49</span>:355–7.</span> [<a href="/pubmed/23968569" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23968569</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.uvarov.2007.30570">Uvarov P, Ludwig A, Markkanen M, Pruunsild P, Kaila K, Delpire E, Timmusk T, Rivera C, Airaksinen MS. A novel N-terminal isoform of the neuron-specific K-Cl cotransporter KCC2. <span><span class="ref-journal">J Biol Chem. </span>2007;<span class="ref-vol">282</span>:30570–6.</span> [<a href="/pubmed/17715129" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17715129</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.uvarov.2009.13696">Uvarov P, Ludwig A, Markkanen M, Soni S, H&#x000fc;bner CA, Rivera C, Airaksinen MS. Coexpression and heteromerization of two neuronal K-Cl cotransporter isoforms in neonatal brain. <span><span class="ref-journal">J Biol Chem. </span>2009;<span class="ref-vol">284</span>:13696–704.</span> [<a href="/pmc/articles/PMC2679471/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2679471</span></a>] [<a href="/pubmed/19307176" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19307176</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.vendrame.2011.18">Vendrame M, Poduri A, Loddenkemper T, Kluger G, Coppola G, Kothare SV. Treatment of malignant migrating partial epilepsy of infancy with rufinamide: report of five cases. <span><span class="ref-journal">Epileptic Disord. </span>2011;<span class="ref-vol">13</span>:18–21.</span> [<a href="/pubmed/21393094" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21393094</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.wolff.2017.1316">Wolff M, Johannesen KM, Hedrich UBS, Masnada S, Rubboli G, Gardella E, Lesca G, Ville D, Milh M, Villard L, Afenjar A, Chantot-Bastaraud S, Mignot C, Lardennois C, Nava C, Schwarz N, G&#x000e9;rard M, Perrin L, Doummar D, Auvin S, Miranda MJ, Hempel M, Brilstra E, Knoers N, Verbeek N, van Kempen M, Braun KP, Mancini G, Biskup S, H&#x000f6;rtnagel K, D&#x000f6;cker M, Bast T, Loddenkemper T, Wong-Kisiel L, Baumeister FM, Fazeli W, Striano P, Dilena R, Fontana E, Zara F, Kurlemann G, Klepper J, Thoene JG, Arndt DH, Deconinck N, Schmitt-Mechelke T, Maier O, Muhle H, Wical B, Finetti C, Br&#x000fc;ckner R, Pietz J, Golla G, Jillella D, Linnet KM, Charles P, Moog U, &#x000d5;iglane-Shlik E, Mantovani JF, Park K, Deprez M, Lederer D, Mary S, Scalais E, Selim L, Van Coster R, Lagae L, Nikanorova M, Hjalgrim H, Korenke GC, Trivisano M, Specchio N, Ceulemans B, Dorn T, Helbig KL, Hardies K, Stamberger H, de Jonghe P, Weckhuysen S, Lemke JR, Kr&#x000e4;geloh-Mann I, Helbig I, Kluger G, Lerche H, M&#x000f8;ller RS. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. <span><span class="ref-journal">Brain. </span>2017;<span class="ref-vol">140</span>:1316–36.</span> [<a href="/pubmed/28379373" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28379373</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.woo.2002.258">Woo NS, Lu J, England R, McClellan R, Dufour S, Mount DB, Deutch AY, Lovinger DM, Delpire E. Hyperexcitability and epilepsy associated with disruption of the mouse neuronal-specific K-Cl cotransporter gene. <span><span class="ref-journal">Hippocampus. </span>2002;<span class="ref-vol">12</span>:258–68.</span> [<a href="/pubmed/12000122" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12000122</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="slc12a5-e.REF.zhang.2014.547">Zhang X, Ling J, Barcia G, Jing L, Wu J, Barry BJ, Mochida GH, Hill RS, Weimer JM, Stein Q, Poduri A, Partlow JN, Ville D, Dulac O, Yu TW, Lam AT, Servattalab S, Rodriguez J, Boddaert N, Munnich A, Colleaux L, Zon LI, S&#x000f6;ll D, Walsh CA, Nabbout R. Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures. <span><span class="ref-journal">Am J Hum Genet. </span>2014;<span class="ref-vol">94</span>:547–58.</span> [<a href="/pmc/articles/PMC3980424/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3980424</span></a>] [<a href="/pubmed/24656866" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24656866</span></a>]</div></li></ul></div></div><div id="slc12a5-e.Chapter_Notes"><h2 id="_slc12a5-e_Chapter_Notes_">Chapter Notes</h2><div id="slc12a5-e.Author_Notes"><h3>Author Notes</h3><p>Dr Amy McTague is a consultant pediatric neurologist and a NIHR Great Ormond Street BRC Catalyst Fellow who has recently completed a PhD investigating the molecular genetics of EIMFS in the Kurian group at the UCL Great Ormond Street Institute of Child Health.</p><p>Dr Manju Kurian is a NIHR Research Professor and group leader in the Developmental Neurosciences programme at the UCL Great Ormond Street Institute of Child Health and a consultant pediatric neurologist at Great Ormond Street Hospital.</p></div><div id="slc12a5-e.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>14 February 2019 (bp) Review posted live</div></li><li class="half_rhythm"><div>13 November 2017 (am) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK537476</span><span class="label">PMID: <a href="/pubmed/30763027" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">30763027</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/lwd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/slc39a14-def/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK537476&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK537476/?report=reader">PubReader</a></li><li><a href="/books/NBK537476/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK537476" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK537476" style="display:none" title="Cite this Page"><div class="bk_tt">McTague A, Kurian MA. SLC12A5-Related Epilepsy of Infancy with Migrating Focal Seizures. 2019 Feb 14. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK537476/pdf/Bookshelf_NBK537476.pdf">PDF version of this page</a> (487K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#slc12a5-e.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#slc12a5-e.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#slc12a5-e.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#slc12a5-e.Genetically_Related_Allelic_Di" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#slc12a5-e.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#slc12a5-e.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#slc12a5-e.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#slc12a5-e.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#slc12a5-e.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#slc12a5-e.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#slc12a5-e.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=57468[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SLC12A5</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4722630" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4722630" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4722630" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4722630" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30234941" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">KCNT1</i>-Related Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Gertler T, Bearden D, Bhattacharjee A, Carvill G. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301601" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neuronal Ceroid-Lipofuscinoses</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Neuronal Ceroid-Lipofuscinoses<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mole SE, Williams RE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301603" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Glucose Transporter Type 1 Deficiency Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wang D, Pascual JM, De Vivo D. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28933809" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Isolated Sulfite Oxidase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Isolated Sulfite Oxidase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bindu PS, Nagappa M, Bharath RD, Taly AB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/27683935" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GRIN2A</i>-Related Speech Disorders and Epilepsy</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">GRIN2A</i>-Related Speech Disorders and Epilepsy<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Myers KA, Scheffer IE. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=30763027" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=30763027" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5dfc93fadde0891169c9dfa0">SLC12A5-Related Epilepsy of Infancy with Migrating Focal Seizures - GeneReviews®</a><div class="ralinkpop offscreen_noflow">SLC12A5-Related Epilepsy of Infancy with Migrating Focal Seizures - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-20T04:27:22-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A1EC4DFC8E3610000000002E30173&amp;ncbi_session=CE8A1EC4DFC93F91_0739SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK537476%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK537476&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK537476/&amp;ncbi_pagename=SLC12A5-Related Epilepsy of Infancy with Migrating Focal Seizures - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A1EC4DFC93F91_0739SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>